These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 27979490

  • 1. Is OM-3 synergistic with GLP-2 in intestinal failure?
    Karmaker A, Costanzo CM, Schwartz MZ.
    J Surg Res; 2017 Jan; 207():7-12. PubMed ID: 27979490
    [Abstract] [Full Text] [Related]

  • 2. Chronology of the effect of massive small bowel resection and hepatocyte growth factor (HGF) on intestinal adaptation.
    Katz MS, Thatch KA, Schwartz MZ.
    J Surg Res; 2011 Dec; 171(2):399-403. PubMed ID: 21658720
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.
    Washizawa N, Gu LH, Gu L, Openo KP, Jones DP, Ziegler TR.
    JPEN J Parenter Enteral Nutr; 2004 Dec; 28(6):399-409. PubMed ID: 15568286
    [Abstract] [Full Text] [Related]

  • 4. Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome.
    Thymann T, Stoll B, Mecklenburg L, Burrin DG, Vegge A, Qvist N, Eriksen T, Jeppesen PB, Sangild PT.
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):694-702. PubMed ID: 24399211
    [Abstract] [Full Text] [Related]

  • 5. Hepatocyte growth factor and omega-3-enriched feeds have a synergistic effect on mucosal mass in an animal model of inflammatory bowel disease.
    Katz MS, Thatch KA, Schwartz MZ.
    J Pediatr Surg; 2012 Jan; 47(1):194-8. PubMed ID: 22244416
    [Abstract] [Full Text] [Related]

  • 6. Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome.
    Lim DW, Levesque CL, Vine DF, Muto M, Koepke JR, Nation PN, Wizzard PR, Li J, Bigam DL, Brubaker PL, Turner JM, Wales PW.
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr 01; 312(4):G390-G404. PubMed ID: 28104586
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glucagonlike peptide-2 analogue enhances intestinal mucosal mass and absorptive function after ischemia-reperfusion injury.
    Rajeevprasad R, Alavi K, Schwartz MZ.
    J Pediatr Surg; 2000 Nov 01; 35(11):1537-9. PubMed ID: 11083417
    [Abstract] [Full Text] [Related]

  • 9. GLP-2alpha accelerates recovery of mucosal absorptive function after intestinal ischemia/reperfusion.
    Prasad R, Alavi K, Schwartz MZ.
    J Pediatr Surg; 2001 Apr 01; 36(4):570-2. PubMed ID: 11283879
    [Abstract] [Full Text] [Related]

  • 10. Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study.
    Madsen KB, Askov-Hansen C, Naimi RM, Brandt CF, Hartmann B, Holst JJ, Mortensen PB, Jeppesen PB.
    Regul Pept; 2013 Jun 10; 184():30-9. PubMed ID: 23511332
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Glucagonlike peptide-2 enhances small intestinal absorptive function and mucosal mass in vivo.
    Kato Y, Yu D, Schwartz MZ.
    J Pediatr Surg; 1999 Jan 10; 34(1):18-20; discussion 20-1. PubMed ID: 10022136
    [Abstract] [Full Text] [Related]

  • 13. Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats.
    Lai SW, de Heuvel E, Wallace LE, Hartmann B, Holst JJ, Brindle ME, Chelikani PK, Sigalet DL.
    PLoS One; 2017 Jan 10; 12(7):e0181453. PubMed ID: 28738080
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of intestinal adaptation by hepatocyte growth factor.
    Kato Y, Yu D, Schwartz MZ.
    J Pediatr Surg; 1998 Feb 10; 33(2):235-9. PubMed ID: 9498393
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enteral glutamine does not enhance the effects of hepatocyte growth factor in short bowel syndrome.
    Alavi K, Kato Y, Yu D, Schwartz MZ.
    J Pediatr Surg; 1998 Nov 10; 33(11):1666-9. PubMed ID: 9856891
    [Abstract] [Full Text] [Related]

  • 17. Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates.
    Vegge A, Thymann T, Lund P, Stoll B, Bering SB, Hartmann B, Jelsing J, Qvist N, Burrin DG, Jeppesen PB, Holst JJ, Sangild PT.
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug 15; 305(4):G277-85. PubMed ID: 23764891
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-11 enhances small intestine absorptive function and mucosal mass after intestinal adaptation.
    Alavi K, Prasad R, Lundgren K, Schwartz MZ.
    J Pediatr Surg; 2000 Feb 15; 35(2):371-4. PubMed ID: 10693699
    [Abstract] [Full Text] [Related]

  • 19. Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum.
    Sigalet DL, Bawazir O, Martin GR, Wallace LE, Zaharko G, Miller A, Zubaidi A.
    Dig Dis Sci; 2006 Sep 15; 51(9):1557-66. PubMed ID: 16927140
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.